Pharmaceutical Perspectives of Cancer Therapeutics

1. Tumor microvasculature and microenvironment: Therapeutic targets for inhibition of angiogenesis and metastasis Chikezie Madu and Yi Lu 2. Anticancer drug development AjitNarang and Divyakant S. Desai 3. Tumor targeted macromolecular drug delivery based on the enhanced permeability and retention effect in solid tumor Takahiro Seki, Jun Fang, and Hiroshi Maeda 4. Multidrug-resistance in solid tumor and its reversal Ho Lun Wong, Xiao Yu Wu, and Reina Bendayan 5. Targeting of apoptosis signaling pathways and their mediators for cancer therapy Arun K. Rishi, Xinbo Zhang, and Anil Wali 6. Role of telomerase in cancer therapeutics Kyung H. Choi and Michel M. Ouellette 7. Polymeric carriers for anticancer drug delivery Dongin Kim and You Han Bae 8. Application of nanobiotechnology in cancer therapeutics Kewal K. Jain 9. Receptor-mediated delivery of proteins and peptides to tumors Christian Dohmen and Manfred Ogris 10. Protein transduction domain-mediated delivery of anti-cancer proteins Hiroshi Harada and Masahiro Hiraoka 11. Current therapeutic uses of monoclonal antibodies Michael Axelson and David Gerber 12. Cancer vaccines ZsuzsannaTabi 13. RNA interference for cancer therapy Kun Cheng and Bin Qin 14. MicroRNAs as therapeutic targets for cancer Guofeng Cheng, Michael Danquah, and Ram I Mahato 15. Targeted therapies for malignant brain tumors Matthew A. Tyler, Adam Quasar Sugihara, Ilya V. Ulasov, and Maciej S. Lesniak 16. The complexity of the HIF-1-dependent hypoxic response in breast cancer presents multiple avenues for therapeutic intervention Tiffany Seagroves 17. Cancer stem cells: potential mediators of therapeutic resistance and novel targets of anti-cancer treatments Hong Yan, Jichao Qin, and Dean G. Tang 18. Image-guided photodynamic cancer therapy Zheng-Rong Lu and AnaghaVaidya 19. Functional imaging of multidrug resistance and its applications Célia Gomes 20.Gene expression microarrays in cancer research Jian Yang and Weikuan Gu 21.Clinical trials and

Yi Lu graduated with B.S. in Biochemistry from Fudan University in Shanghai, China in 1984, and Ph.D. in Biochemistry and Molecular Biology from University of Nebraska Medical Center, Omaha, NE, USA in 1992. He is currently an Associate Professor at the Departments of Pathology, Medicine, and Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA. His research interests include tumor angiogenesis and metastasis, gene therapy for prostate cancer and breast cancer, targeted gene expression, and exploration of novel apoptosis-inducing genes. He has more than 50 publications and holds five patents.

Ram I Mahato is a full time Associate Professor in the Department of Pharmaceutical Sciences at the University of Health Science Center Memphis. He was a Research Assistant Professor at the University of Utah Salt Lake City, Senior Scientist at GeneMedicine, Inc., The Woodland, TX, and postdoctoral fellow at the University of Southern California in Los Angeles, Washington University in St Louis and Kyoto University, Japan. He received his B.S. in Pharmaceutics from China Pharmaceutical University in 1989 and PhD in Pharmaceutics and Drug Delivery from the University of Strathclyde in 1992. He is an author or co-author of 79 peer reviewed articles and book chapters. He has also edited/written three books and is a special features editor of Pharmaceutical Research and on the editorial board of the Journal of Drug Targeting, Expert Opinion on Drug Delivery, and Transplantation and Risk Management. His research includes delivery and targeting of small molecules, oligonucleotides, siRNA and genes.